Literature DB >> 3227809

Parkinsonism induced by pyridostigmine.

Y Iwasaki, N Wakata, M Kinoshita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3227809     DOI： 10.1111/j.1600-0404.1988.tb03653.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  5 in total

1.  Pyridostigmine in the treatment of orthostatic hypotension.

Authors:  Jean-Michel Senard
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

2.  [Myasthenia gravis should be considered in cases of Parkinson's disease and progressive dysphagia].

Authors:  P P Urban; O Stammel
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 3.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

4.  The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.

Authors:  Adrienne J Betz; Peter J McLaughlin; Melissa Burgos; Suzanne M Weber; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2007-06-27       Impact factor: 4.530

5.  Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.

Authors:  Anna Wisniecki; Merce Correa; Maria N Arizzi; Keitha Ishiwari; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.